Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/14/22 → 2/21/24 |
Funding
- Rakuten Medical Incorporated: $23,412.00
A Phase 1 First-in-Human, Drug-dose Escalation Study of RM-1995 Photoimmunotherapy, as Monotherapy or Combined with Pembrolizumab, in Patients With Advanced Cutaneous Squamous Cell Carcinoma or With Head and Neck Squamous Cell Carcinoma
- Valentino, Joseph (PI)